In vivo inferiority of generic product compared with branded vancomycin: a paradigm shift.
Division of Clinical Pharmacology & Toxicology, Hospital for Sick Children, Toronto, Ontario, Canada.
G W 't
GW
Jong
D000818:Animals; D000900:Anti-Bacterial Agents / Q000493:pharmacokinetics; D016568:Drugs, Generic / Q000191:economics / Q000493:pharmacokinetics*; D006801:Humans; D051379:Mice; D013203:Staphylococcal Infections / Q000188:drug therapy / Q000382:microbiology; D013211:Staphylococcus aureus; D013810:Therapeutic Equivalency; D014640:Vancomycin / Q000493:pharmacokinetics*
D000900:Anti-Bacterial Agents; D016568:Drugs, Generic; D014640:Vancomycin